跳至主要内容
临床试验/NCT00899795
NCT00899795已完成不适用

Stromal Injury and Clonal Adaptation in Myelodysplasia

OHSU Knight Cancer Institute1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2002年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
Abnormal stromal function

研究概览

简要总结

RATIONALE: Studying samples of bone marrow from patients with cancer and from healthy volunteers in the laboratory may help doctors learn more about changes that occur in bone marrow stromal (connective tissue) cells. It may also help doctors understand the effects of alkylating agents on bone marrow stromal cells.

PURPOSE: This laboratory study is evaluating stromal cells in patients with acute myeloid leukemia, myelodysplastic syndromes, or Fanconi anemia; in patients who were exposed to alkylating agents; and in healthy volunteers.

详细描述

OBJECTIVES:

Primary

  • Determine abnormal stromal function in patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or Fanconi anemia; in patients who were exposed to alkylating agents; and in healthy volunteers.

Secondary

  • Determine whether clonal progenitors from patients with secondary AML or MDS are resistant to selected extracellular apoptotic cues.
  • Determine whether stromal function in patients with secondary AML or MDS is more aberrant than stromal function in patients with primary AML or MDS.
  • Determine whether cytotoxic agents known to induce secondary MDS or AML influence the supportive function of the bone marrow stroma.
  • Determine whether cytoprotective agents reduce both cytotoxicity and genotoxicity in hematopoietic progenitor cells and stromal cells.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
5 Years 至 120 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Abnormal stromal function

次要结局

  • Clonal progenitors resistant to selected extracellular apoptotic cells
  • Influence of cytotoxic agents on supportive function of the bone marrow stroma
  • Comparison of stromal function between secondary vs primary acute myeloid leukemia or myelodysplastic syndromes
  • Reduction of cytotoxicity and genotoxicity in hematopoietic progenitor cells and stromal cells with use of cytoprotective agents

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Grover Bagby

Professor Emeritus

OHSU Knight Cancer Institute

研究点 (1)

Loading locations...

相似试验